| The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis J Sieper, M Rudwaleit, X Baraliakos, J Brandt, J Braun, R Burgos-Vargas, ... Annals of the rheumatic diseases 68, ii1-ii44, 2009 | 2234 | 2009 |
| 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis D Van Der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ... Annals of the rheumatic diseases 76 (6), 978-991, 2017 | 1961 | 2017 |
| 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis JV Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, ... Annals of the rheumatic diseases 70 (6), 896-904, 2011 | 1556 | 2011 |
| Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis D Baeten, J Sieper, J Braun, X Baraliakos, M Dougados, P Emery, ... New England journal of medicine 373 (26), 2534-2548, 2015 | 1165 | 2015 |
| Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group M Rudwaleit, AG Jurik, KGA Hermann, R Landewé, D van der Heijde, ... Annals of the rheumatic diseases 68 (10), 1520-1527, 2009 | 1138 | 2009 |
| EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ... Annals of the rheumatic diseases 79 (6), 700-712, 2020 | 1075 | 2020 |
| The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort M Rudwaleit, H Haibel, X Baraliakos, J Listing, E Märker‐Hermann, ... Arthritis & Rheumatism: official Journal of the american College of …, 2009 | 1016 | 2009 |
| Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force JS Smolen, M Schöls, J Braun, M Dougados, O FitzGerald, DD Gladman, ... Annals of the rheumatic diseases 77 (1), 3-17, 2018 | 784 | 2018 |
| Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial D Baeten, X Baraliakos, J Braun, J Sieper, P Emery, D Van der Heijde, ... The Lancet 382 (9906), 1705-1713, 2013 | 758 | 2013 |
| EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice P Mandl, V Navarro-Compán, L Terslev, P Aegerter, D Van Der Heijde, ... Annals of the rheumatic diseases 74 (7), 1327-1339, 2015 | 671 | 2015 |
| ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update S Ramiro, E Nikiphorou, A Sepriano, A Ortolan, C Webers, X Baraliakos, ... Annals of the rheumatic diseases 82 (1), 19-34, 2023 | 651 | 2023 |
| Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force JS Smolen, J Braun, M Dougados, P Emery, O FitzGerald, P Helliwell, ... Annals of the rheumatic diseases 73 (1), 6-16, 2014 | 641 | 2014 |
| Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis D Heijde, R Landewé, X Baraliakos, H Houben, A Tubergen, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 634 | 2008 |
| International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ... Annals of the rheumatic diseases 62 (9), 817-824, 2003 | 632 | 2003 |
| Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group RGW Lambert, PAC Bakker, D van der Heijde, U Weber, M Rudwaleit, ... Annals of the rheumatic diseases 75 (11), 1958-1963, 2016 | 563 | 2016 |
| Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept J Braun, X Baraliakos, J Listing, J Sieper Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 554 | 2005 |
| Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring … J Braun, X Baraliakos, W Golder, J Brandt, M Rudwaleit, J Listing, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 525 | 2003 |
| Do patients with non‐radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? U Kiltz, X Baraliakos, P Karakostas, M Igelmann, L Kalthoff, C Klink, ... Arthritis care & research 64 (9), 1415-1422, 2012 | 441 | 2012 |
| Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis H Appel, G Ruiz‐Heiland, J Listing, J Zwerina, M Herrmann, R Mueller, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 402 | 2009 |
| Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab X Baraliakos, J Listing, J Brandt, M Rudwaleit, J Sieper, J Braun Arthritis research & therapy 7, 1-6, 2005 | 353 | 2005 |